RIABNI Trademark
RIABNI is a USPTO trademark filed by Amgen Inc.. Status: Registered.
Trademark Facts
| Mark | RIABNI |
|---|---|
| Serial Number | 88182290 |
| Registration Number | 6809212 |
| Status | Registered |
| Filing Date | 2018-11-05 |
| Registration Date | 2022-08-02 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Amgen Inc. |
| Attorney of Record | Elsa D. Lemoine |
| Prosecution Events | 55 |
| Latest Event | COAR on 2025-02-25 |
Goods & Services
Pharmaceutical preparations for treatment of inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA)